taVNS Reduces Postoperative Pain and Complications in Patients With Gastric and Intestinal Tumors

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

July 30, 2025

Study Completion Date

July 30, 2025

Conditions
taVNSGastrointestinal Tumor SurgeryVisual Analogue ScaleComplications
Interventions
DEVICE

taVNS

Set the pulse width to 200 microseconds, frequency to 30 Hz, and start the current at 10 mA. Gradually increase the current until the patient reaches their pain tolerance threshold, and cap it at 50 mA,last for one hour.During the intervention, dynamic ECG monitoring was conducted using an ECG monitor, starting 10 minutes before the stimulation and ending 10 minutes after the stimulation.

DEVICE

sham taVNS

Set the pulse width to 200 microseconds, frequency to 1 Hz, and start the current at 10 mA. Gradually increase the current until the patient reaches their pain tolerance threshold, and cap it at 50 mA,last for one hour.During the intervention, dynamic ECG monitoring was conducted using an ECG monitor, starting 10 minutes before the stimulation and ending 10 minutes after the stimulation.

Trial Locations (1)

310000

Second affiliated Hospital School of Medicine, Hangzhou

All Listed Sponsors
lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

NCT06763913 - taVNS Reduces Postoperative Pain and Complications in Patients With Gastric and Intestinal Tumors | Biotech Hunter | Biotech Hunter